A phase II study of the cancer vaccine GVAX in patients with chronic myeloid leukaemia.

Trial Profile

A phase II study of the cancer vaccine GVAX in patients with chronic myeloid leukaemia.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Imatinib; Tumour cell vaccine-GVAX
  • Indications Chronic myeloid leukaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Mar 2010 Results reported in BioSante media release.
    • 03 Jun 2006 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top